JYJuan Yang

Juan Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Juan Yang has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Transglutaminase‐2 Promotes Microglial Synaptic Phagocytosis and Ameliorates Epileptic Seizures by Inhibiting ABCA1 Ubiquitination

    by Zunlin Zhou, Xiujuan Wang, Juan Yang, Jiyao Qin, Bidan Feng, Qianqiong Qin, Jun Tian, Zhong Luo, Xiaoyan Yang, Hao Huang, et al.

    Background: Epilepsy is a prevalent chronic neurological disorder characterized by its complex pathophysiology, with microglial phagocytosis being crucial for synaptic remodeling and epileptogenesis. Transglutaminase‐2 (TGM2) holds a critical role in regulating microglial function and cognitive synaptic plasticity; however, the precise mechanisms by which TGM2 influences synaptic pruning and epileptogenesis remain unclear. Aim: This study aims to investigate the role of TGM2 in seizure susceptibility and its regulatory effects on microglial‐mediated synaptic phagocytosis in a chronic epilepsy model. Accordingly, the following objectives were set: elucidate the fluorescent localization and protein expression characteristics of TGM2 in normal and epileptic brain tissues; analyze the impact of TGM2 on epileptic behavioral phenotypes; and investigate the molecular mechanisms underlying its regulation of microglial activation and synaptic phagocytic function using an epileptic mouse model. Methods: In vivo experiments were performed using a kainic acid (KA)–induced chronic epilepsy mouse model established via intrahippocampal injection. Western blot and immunofluorescence analyses were employed to examine TGM2 expression and localization in the hippocampus of KA‐treated mice. Adeno‐associated virus vectors were used to achieve TGM2 overexpression or knockdown in the hippocampus, after which video‐monitored behavioral assays and in vivo field potential recordings were used to evaluate seizure latency, frequency, and severity. Golgi–Cox staining, western blotting, and immunofluorescence were used to assess dendritic spine density in the hippocampal CA1 region, microglial polarization (M1/M2 phenotypes), and phagocytic activity. In vitro studies in BV2 microglia explored the molecular mechanisms of action of TGM2 using ubiquitination assays targeting ATP‐binding cassette transporter A1 (ABCA1). Results: TGM2 expression was significantly upregulated in the hippocampus of KA‐induced epileptic mice, which prolonged the latency period to spontaneous recurrent seizures (SRS) and reduced SRS frequency. In contrast, TGM2 knockdown exacerbated seizure severity, which was characterized by a shortened latency period and increased SRS frequency. Golgi–Cox staining revealed that TGM2 overexpression decreased dendritic spine density in the CA1 region, whereas TGM2 knockdown had the opposite effect, indicating a role in synaptic remodeling. Functional analyses showed that TGM2 promoted microglial polarization toward an anti‐inflammatory M2 phenotype, enhanced phagocytic activity, and upregulated the components of the complement system as well as the phagocytosis‐related proteins. Conversely, TGM2 deficiency promoted the pro‐inflammatory M1 phenotype, reduced phagocytic capacity, and downregulated the components of the complement system and the phagocytosis‐related proteins. Mechanistically, TGM2 overexpression increased ABCA1 protein stability by inhibiting its ubiquitination, whereas TGM2 knockdown promoted ABCA1 ubiquitination and degradation. Immunofluorescence analysis revealed enhanced colocalization of TGM2 within the microglia. Conclusion: This study revealed that TGM2 suppresses epileptogenesis by enhancing microglial synaptic phagocytosis through the inhibition of ABCA1 ubiquitination, thereby regulating synaptic remodeling in the hippocampus. These findings establish a critical molecular link between TGM2‐mediated microglial function and epileptogenesis, providing novel insights into therapeutic strategies targeting neuroinflammation and synaptic plasticity in epilepsy.


  • Open Access

    The JNK Signaling Pathway Regulates Seizures Through ENT1 in Pilocarpine‐Induced Epilepsy Rat Model

    by Shun Liu, Zhong Luo, Fangjing Li, Lijia Zhang, Mingxiang Xie, Juan Yang, Zucai Xu

    Objective: The study investigates whether the expression and function of ENT1 can be regulated by inhibiting the JNK signaling pathway, thereby altering the levels of extracellular adenosine and glutamate in neurons, and subsequently affecting the progression of epilepsy.Methods: The adult male SD rats were randomly divided into four groups: EP + SP600125 group, EP + DMSO group, EP group, and normal control group. The expression levels of ENT1, p‐JNK, and JNK in the hippocampus of rats from each experimental group were detected using Western blotting technology. The expression and localization of ENT1 and p‐JNK in the CA1, CA3, and DG areas of the hippocampus were detected by immunohistochemical staining and immunofluorescence staining. Microdialysis combined with liquid chromatography‐mass spectrometry was used to determine the concentrations of adenosine and glutamate in the extracellular fluid of hippocampus in each experimental group.Results: This study showed that the JNK‐specific inhibitor SP600125 could reduce ENT1 expression and seizure intensity in experimental rats. Statistical analysis confirmed that adenosine and glutamate levels in the extracellular fluid of the hippocampus increased significantly after seizures in rats, and the JNK‐specific inhibitor SP600125 could increase adenosine levels in the extracellular fluid but decrease glutamate levels.Significance: The JNK‐specific inhibitor SP600125 can specifically inhibit the JNK signaling pathway and reduce the expression of ENT1 transporter. The mechanism is related to the transport of adenosine from the extracellular space to the intracellular space by ENT1 during epileptic states. Inhibition of ENT1 can increase the concentration of adenosine in the extracellular fluid of the hippocampus. The increase in adenosine concentration stopped glutamate from being released and reduced the amount of glutamate in the outside of the cell.


  • Open Access

    Transmembrane protein modulates seizure in epilepsy: evidence from temporal lobe epilepsy patients and mouse models

    by Haiqing Zhang, Zunlin Zhou, Jiyao Qin, Juan Yang, Hao Huang, Xiaoyan Yang, Zhong Luo, Yongsu Zheng, Yan Peng, Ya Chen, et al.

    Transmembrane protein (TMEM230) is located in secretory/recycling vesicles, including synaptic vesicles in neurons. However, the functional relationship between TMEM230 and epilepsy is still a mystery. The aims of this study were to investigate the expression of TMEM230 in patients with temporal lobe epilepsy (TLE) and two different mice models of chronic epilepsy, and to determine the probable roles of TMEM230 in epilepsy. Our results showed that TMEM230 expression was increased in the temporal neocortex of epileptic patients and the hippocampus and cortex of epileptic mice compared with that in the control tissues. Moreover, TMEM230 was mainly expressed in the neurons in both humans and mice epileptic brain. TMEM230 co-localized with glutamate vesicular transporter 1 (VGLUT-1), but not with vesicular GABA transporter (VGAT). Mechanistically, coimmunoprecipitation confirmed that TMEM230 interacted with VGLUT-1, but not with VGAT in the hippocampus of epileptic mice. Lentivirus mediated overexpression of TMEM230 increased mice susceptibility to epilepsy and behavioural phenotypes of epileptic seizures during the kainite (KA)-induced chronic phase of epileptic seizures and the pentylenetetrazole (PTZ) kindling process, whereas lentivirus-mediated TMEM230 downregulation had the opposite effect. These results shed light on the functions of TMEM230 in neurons, suggesting that TMEM230 may play a critical role in the regulation of epileptic activity via influencing excitatory neurotransmission.


  • Open Access

    Hereditary motor and sensory neuropathy with SOD1-mutant: A case report

    by Zhong Luo, Linhai Zhang, Juan Yang, Haiqing Zhang, Tao Liang

    Rationale: Hereditary motor-sensory peripheral neuropathy, or Charot-Marie-Tooth (CMT) Charcot-Marie-Tooth disease is an inherited peripheral neuropathy characterized by progressive limb weakness and muscle atrophy. As the disease progresses, sensory and autonomic involvement may occur. We report a case of CMT associated with SOD1 gene mutation, in order to provide new ideas for clinical disease diagnosis. Patient concerns: A 50-years-old female patient was admitted to the hospital with “progressive weakness of the right lower extremity for 5 years, aggravating, and weakness of the left lower extremity for 4 months”. Diagnosis: The patient was diagnosed CMT. Intervention: Nerve nutrition and rehabilitation therapy were given, but the patient’s condition still did not improve significantly. Outcomes: The improvement of symptoms was not obvious. Lessons: The clinical manifestations and electromyography results of this patient are consistent with the characteristics of CMT. The peripheral nerve-related hereditary gene test found mutation in SOD1. It is possible that this mutation is linked to CMT. The disease is a neurodegenerative disease, that may be slowed by physical therapy and rehabilitation, but could not be healed.


  • Open Access

    G‐alpha interacting protein interacting protein, C terminus 1 regulates epileptogenesis by increasing the expression of metabotropic glutamate receptor 7

    by Yong Liu, You Wang, Juan Yang, Tao Xu, Changhong Tan, Peng Zhang, Qiankun Liu, Yangmei Chen

    Aims: It has been reported that the G‐alpha interacting protein (GAIP) interacting protein, C terminus 1 (GIPC1/GIPC) engages in vesicular trafficking, receptor transport and expression, and endocytosis. However, its role in epilepsy is unclear. Therefore, in this study, we aimed to explore the role of GIPC1 in epilepsy and its possible underlying mechanism.Methods: The expression patterns of GIPC1 in patients with temporal lobe epilepsy (TLE) and in mice with kainic acid (KA)‐induced epilepsy were detected. Behavioral video monitoring and hippocampal local field potential (LFP) recordings were carried out to determine the role of GIPC1 in epileptogenesis after overexpression of GIPC1. Coimmunoprecipitation (Co‐IP) assay and high‐resolution immunofluorescence staining were conducted to investigate the relationship between GIPC1 and metabotropic glutamate receptor 7 (mGluR7). In addition, the expression of mGluR7 after overexpression of GIPC1 was measured, and behavioral video monitoring and LFP recordings after antagonism of mGluR7 were performed to explore the possible mechanism mediated by GIPC1.Results: GIPC1 was downregulated in the brain tissues of patients with TLE and mice with KA‐induced epilepsy. After overexpression of GIPC1, prolonged latency period, decreased epileptic seizures and reduced seizure severity in behavioral analyses, and fewer and shorter abnormal brain discharges in LFP recordings of KA‐induced epileptic mice were observed. The result of the Co‐IP assay showed the interaction between GIPC1 and mGluR7, and the high‐resolution immunofluorescence staining also showed the colocalization of these two proteins. Additionally, along with GIPC1 overexpression, the total and cell membrane expression levels of mGluR7 were also increased. And after antagonism of mGluR7, increased epileptic seizures and aggravated seizure severity in behavioral analyses and more and longer abnormal brain discharges in LFP recordings were observed.Conclusion: GIPC1 regulates epileptogenesis by interacting with mGluR7 and increasing its expression.


  • Open Access

    STK24 modulates excitatory synaptic transmission in epileptic hippocampal neurons

    by Juan Yang, Qian Jiang, Xinyuan Yu, Tao Xu, You Wang, Jing Deng, Yong Liu, Yangmei Chen

    Introduction: A large amount of literature has indicated that excitatory synaptic transmission plays a crucial role in epilepsy, but the detailed pathogenesis still needs to be clarified.Methods: In the present study, we used samples from patients with temporal lobe epilepsy, pentylenetetrazole‐kindled mice, and Mg2+‐free‐induced epileptic cultured hippocampal neurons to detect the expression pattern of STK24. Then, the whole‐cell recording was carried out after STK24 overexpression in the Mg2+‐free‐induced epileptic cultured hippocampal neurons. In addition, coimmunoprecipitation was performed to detect the association between endogenous STK24 and main subunits of NMDARs and AMPARs in the hippocampus of PTZ‐kindled mice.Results: Here, we reported that STK24 was specifically located in epileptic neurons of human and pentylenetetrazole‐kindled mice. Meanwhile, the expression of STK24 was significantly down‐regulated in these samples which are mentioned above. Besides, we found that the amplitude of miniature excitatory postsynaptic currents was increased in STK24 overexpressed epileptic hippocampal cultured neurons, which means the excitatory synaptic transmission was changed. Moreover, the coimmunoprecipitation, which further supported the previous experiment, indicated an association between STK24 and the subunits of the NMDA receptor.Conclusion: These findings expand our understanding of how STK24 involved in the excitatory synaptic transmission in epilepsy and lay a foundation for exploring the possibility of STK24 as a drug target.